High costs, investor exit prompt closure of cell therapy biotech Walking Fish

10h ago, source: FierceBiotech

The biotech previously received funding from Illumina’s venture arm, Quan Capital and the Emerson Collective. Less than a year ago, the company was adding to its ... CEO for more than 15 years before ...

Biotech in New Jersey: Nine companies leading the charge

15h ago, source: labiotech

Delve into one of the most dynamic biotech region in the U.S. and discover nine New-Jersey-based companies to put on your radar.

Biotech Acquisition Company

11d ago, source: TheStreet.com

Mortgage rates climbed to 7.1%, marking the third straight week of gains. Here's a look at what to expect from the housing market in the months ahead.

Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare

on MSN ago, source:

Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be ...

Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Emergent BioSolutions reduces workforce by 300 workers

4d ago, source: FierceBiotech

The larger biotech's parent company Roche announced cuts to its ... Two months after closing its multibillion-dollar acquisition of Mirati Therapeutics, BMS is bidding adieu to 252 workers at ...

Novartis extends radiopharma plans with $1 billion acquisition

5d ago, source: STAT

Novartis already produces the leading drug in the radiopharmaceutical field. Now, it is devoting even more attention to these ...

Biotech Sector: M&A Fuels Renewed Excitement

7d ago, source: TipRanks on MSN

In today’s world of healthcare and medicine, something exciting is brewing. This is because the big pharmaceutical companies ...

Sino Biological Completes Acquisition of SignalChem Biotech

8d ago, source: GEN

SignalChem Biotech will bring exclusive expertise in enzyme production to Sino Biologicals' existing technology platforms.

Biotech giant lays groundwork for divestiture of early-cancer test maker Grail

5h ago, source: The Business Journals

Illumina's August 2021 acquisition of Grail hung over the company as activist investor Carl Icahn last year complained about a falling stock price. Icahn's efforts resulted in the exit of CEO Francis ...

Biogen: Don’t expect any big acquisitions this year

13d ago, source: BioPharma Dive

While the company is eager to diversify, CEO Chris Viehbacher said that in the near-term any dealmaking would likely focus on collaborations and early-stage assets.

Can biotech startups upstage Eli Lilly and Novo Nordisk?

7d ago, source: The Economist

Unlisted biotech startups have, like most young firms, struggled to attract capital. Last year they drew just $17bn in ...